Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

I Judson, JA Radford, M Harris, JY Blay, Q van Hoesel, A le Cesne, AT van Oosterom, MJ Clemons, C Kamby, C Hermans, J Whittaker, E Donato di Paola, Jaap Verweij, S Nielsen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)870-877
Number of pages8
JournalEuropean Journal of Cancer
Volume37
Publication statusPublished - 2001

Cite this